Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT02977936

Completed

Management of Joint Pain Associated With Osteoarthritis of the Knee With Association of Plant Extracts.

Gonarthrosis
NCT01214317

Completed

Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis (IMPAMS)

Multiple Sclerosis
NCT04413682

Completed

Telerehabilitation vs Supervised Exercises in MS

Multiple Sclerosis
NCT04279912

Unknown

MR-Guided Focused Ultrasound (MRgFUS) for the Management of Tremor in Patients With Multiple Sclerosis (MSFUS001)

Multiple Sclerosis
NCT04073940

Unknown

Exploration of Brain Changes Due to a Targeted Ballet Program in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT04210960

Unknown

Correlation of Serum Lactate and Activity of Multiple Sclerosis

Multiple Sclerosis
NCT02423083

Terminated

Oral Guanabenz for Multiple Sclerosis

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT02633033

Completed

Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse

Multiple Sclerosis, Relapsing-Remitting
NCT01143441

Completed

Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT02834260

Completed

Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study (IDEXACOR)

Keratoconus | Fuchs' Endothelial Dystrophy | Congenital Hereditary Stromal Dystrophy of the Cornea
NCT00242177

Completed

Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

Multiple Sclerosis, Relapsing-Remitting
NCT02525874

Completed

Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT02949908

Terminated

MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS) (MESTRE-MS)

Multiple Sclerosis
NCT00270816

Completed

Interferon ß-1b Treatment by Cyclical Administration

Multiple Sclerosis
NCT02275741

Completed

Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT01585766

Completed

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis, Relapsing Forms
NCT01918800

Completed

A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis

Multiple Sclerosis
NCT02340754

Completed

Mindfulness-based Stress Reduction for Multiple Sclerosis

Multiple Sclerosis
NCT01466322

Completed

A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. (P1A114919)

Multiple Sclerosis, Relapsing-Remitting
NCT00071838

Completed

Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT01808482

Terminated

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting
NCT02377323

Completed

Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif (RLO)

Multiple Sclerosis
NCT02010398

Completed

Effects of the Cross-Training in Patients With Multiple Sclerosis (CTSM)

Multiple Sclerosis | Fatigue | Weakness
NCT00076934

Completed

Safety of RG2077 in Patients With Multiple Sclerosis

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting
NCT00027300

Completed

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT01547351

Completed

Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire (ARMS)

Multiple Sclerosis
NCT01116427

Completed

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Multiple Sclerosis, Relapsing-Remitting
NCT02218879

Terminated

Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS

Multiple Sclerosis
NCT01772199

Completed

Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT02771652

Completed

Effect of an Internet-based At-home Physical Training Protocol on Quality of Life, Fatigue, Functional Performance, Aerobic Capacity and Muscle Strength in Multiple Sclerosis Patients (ms-intakt)

Multiple Sclerosis
NCT02280876

Completed

Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS) (PCNS-EM)

Multiple Sclerosis, Relapsing-Remitting
NCT00220779

Completed

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis (PRIVIG)

Multiple Sclerosis, Relapsing-Remitting
NCT02141386

Unknown

Computerized Cognitive Exercise Training Treatment for Adults With Multiple Sclerosis

Multiple Sclerosis
NCT01279876

Completed

Melatonin in Relapsing-Remitting Multiple Sclerosis Patients

Multiple Sclerosis, Relapsing-Remitting
NCT00202254

Completed

Multiple Sclerosis Rehabilitation Study

Multiple Sclerosis
NCT00459667

Completed

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose (Beyond)

Multiple Sclerosis, Relapsing-Remitting
NCT00050778

Completed

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT02030197

Completed

Impact of CRISP on Self-Efficacy, Loneliness, and Depression (CRISP)

Multiple Sclerosis
NCT00530348

Completed

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One (CARE-MS I)

Multiple Sclerosis, Relapsing-Remitting
NCT00441103

Completed

A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis (IMPROVE)

Multiple Sclerosis, Relapsing-Remitting
NCT00235989

Completed

Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
NCT00420992

Completed

A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee

Osteoarthritis | Chronic Pain
NCT01075880

Completed

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif® (SKORE)

Multiple Sclerosis, Relapsing-Remitting
NCT01492023

Completed

The Effects of Attention Retraining in MS (MSattention)

Multiple Sclerosis
NCT00604539

Completed

Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee

Joint Diseases | Osteoarthritis | Synovitis | Muskuloskeletal Diseases
NCT01017159

Completed

Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
NCT00395200

Completed

Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) (MSCIMS)

Multiple Sclerosis
NCT01097538

Completed

Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS)

Multiple Sclerosis
NCT00203112

Completed

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline

Relapse Remitting Multiple Sclerosis
NCT01158183

Completed

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis (ROBUST)

Multiple Sclerosis, Relapsing-Remitting

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations